Results 11 to 20 of about 69,866 (217)

Migraine pharmacology and brain ischemia [PDF]

Research Results in Pharmacology, 2021
Introduction: The aim of this review article was to analyze in details the mechanism of drugs’ effects in the treatment and prevention of a migraine attack, as well as to discuss the hypotheses of migraine pathogenesis.
Ruben S. Mirzoyan, Tamara S. Gan’shina, Ilya N. Kurdyumov, Denis V. Maslennikov, Anna V. Gnezdilova, Alexander A. Gorbunov, Elena V. Kursa, Antonina I. Turilova, Leonid M. Kostochka, Narine R. Mirzoyan   +9 more
doaj   +3 more sources

Sinonasal symptoms in migraine without aura: results from the cross-sectional ‘Migraine in Poland’ study

Frontiers in Neurology, 2023
BackgroundMigraine without aura (MwoA) is often mistaken for rhinosinusitis. The purpose of this study was to assess the prevalence of sinonasal symptoms, sinusitis-targeting medication use and burden of migraine in a large group of people with MwoA ...
Marcin Straburzynski, Magdalena Nowaczewska, Ewa K. Czapinska-Ciepiela, Anna Gryglas-Dworak, Slawomir Budrewicz, Marta Waliszewska-Prosół   +5 more
doaj   +1 more source

Ubrogepant to Treat Acute Migraine in Adults

Neurology International, 2021
Migraine is a neurobiological headache disorder that affects around 16% of adults in the United States. Medical treatment of mild to moderate migraines include non-prescription non-steroidal anti-inflammatory drugs, acetaminophen, or aspirin and caffeine-
Amber N. Edinoff, C. Austin Casey, Marc A. Colon, Alexa R. Zaheri, Courtney M. Gregoire, Margaret M. Bourg, Alan D. Kaye, Jessica S. Kaye, Adam M. Kaye, Rachel J. Kaye, Sridhar R. Tirumala, Omar Viswanath, Ivan Urits   +12 more
doaj   +1 more source

Gender Differences in 3-Month Outcomes of Erenumab Treatment—Study on Efficacy and Safety of Treatment With Erenumab in Men

Frontiers in Neurology, 2021
Objective: We reported gender-specific data on the efficacy and safety of erenumab, a monoclonal antibody antagonizing the calcitonin gene-related peptide (CGRP) receptor.Methods: Our pooled patient-level analysis of real-world data included patients ...
Raffaele Ornello, Carlo Baraldi, Simona Guerzoni, Giorgio Lambru, Matteo Fuccaro, Bianca Raffaelli, Astrid Gendolla, Piero Barbanti, Piero Barbanti, Cinzia Aurilia, Sabina Cevoli, Valentina Favoni, Fabrizio Vernieri, Claudia Altamura, Antonio Russo, Marcello Silvestro, Elisabetta Dalla Valle, Andrea Mancioli, Angelo Ranieri, Gennaro Alfieri, Nina Latysheva, Elena Filatova, Jamie Talbot, Shuli Cheng, Dagny Holle, Armin Scheffler, Tomáš Nežádal, Dana Čtrnáctá, Jitka Šípková, Zuzana Matoušová, Lucia Sette, Alfonsina Casalena, Maurizio Maddestra, Stefano Viola, Giannapia Affaitati, Maria Adele Giamberardino, Francesca Pistoia, Uwe Reuter, Uwe Reuter, Simona Sacco   +39 more
doaj   +1 more source

Migraine: Advances in the Pathogenesis and Treatment

Neurology International, 2023
This article presents a comprehensive review on migraine, a prevalent neurological disorder characterized by chronic headaches, by focusing on their pathogenesis and treatment advances.
Horia Pleș, Ioan-Alexandru Florian, Teodora-Larisa Timis, Razvan-Adrian Covache-Busuioc, Luca-Andrei Glavan, David-Ioan Dumitrascu, Andrei Adrian Popa, Andrei Bordeianu, Alexandru Vlad Ciurea   +8 more
doaj   +1 more source

Effectiveness of Transcranial Direct Current Stimulation and Monoclonal Antibodies Acting on the CGRP as a Combined Treatment for Migraine (TACTIC): Protocol for a Randomized, Double-Blind, Sham-Controlled Trial

Frontiers in Neurology, 2022
BackgroundMigraine is a recurrent headache disorder that has a still unclear pathophysiology, involving several circuits of both the central and peripheral nervous system.
Raffaele Ornello, Chiara Rosignoli, Valeria Caponnetto, Francesca Pistoia, Michele Ferrara, Aurora D'Atri, Simona Sacco   +6 more
doaj   +1 more source

Migraine in children and adolescents: modern principles of diagnostics and treatment

Неврология, нейропсихиатрия, психосоматика, 2021
Migraine is a nervous system disorder that affects 7.7% of children and can debut before the age of 3 years. As they get older, the incidence of migraine increases, and among adolescents, its prevalence reaches 15%.
V. A. Golovacheva, A. A. Golovacheva, L. M. Antonenko   +2 more
doaj   +1 more source

Combining patient reported outcomes and EHR data to understand population level treatment needs: correcting for selection bias in the migraine signature study

Journal of Patient-Reported Outcomes, 2021
Background Electronic health records (EHR) data can be used to understand population level quality of care especially when supplemented with patient reported data. However, survey non-response can result in biased population estimates.
Walter F. Stewart, Xiaowei Yan, Alice Pressman, Alice Jacobson, Shruti Vaidya, Victoria Chia, Dawn C. Buse, Richard B. Lipton   +7 more
doaj   +1 more source

Cerebral metabolic mechanisms of migraine

Chinese Journal of Contemporary Neurology and Neurosurgery, 2022
Migraine is one of the most common primary headaches, but its pathogenesis remains unclear. Recent studies have found that the onset of migraine may be a response to the imbalance of brain energy metabolism and oxidative stress, suggesting that migraine ...
JIN Hai⁃di , PAN Meng⁃xiong, CHEN Mei⁃jiao, LIU Kai⁃ming   +3 more
doaj   +1 more source

Results of the gErman migraine PatIent Survey on medical Care and prOPhylactic treatment Experience (EPISCOPE)

Scientific Reports, 2022
Migraine affects about 12% of the worldwide population causing substantial personal and societal burden. Yet, migraine remains underdiagnosed and untreated.
Marie Groth, Zaza Katsarava, Marc Ehrlich   +2 more
doaj   +1 more source